Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

2.3K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Cancer Prevention02:59

Cancer Prevention

3.0K
3.0K
Cancer Prevention02:59

Cancer Prevention

8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

783
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
783
Uterus and Cervix01:18

Uterus and Cervix

7.1K
The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self-Collected HPV Testing for Cervical Cancer Screening-Responsible Implementation to Reduce Disparities.

JAMA internal medicine·2026
Same author

Monitoring After Treatment of Precancerous Cervical Lesions.

JAMA internal medicine·2026
Same author

Preferences Among U.S. Women for Cervical Cancer Screening with Self-Collected Specimens for Human Papillomavirus Testing.

Obstetrics and gynecology·2025
Same author

The impact of age at initial HPV vaccination on cervical cancer screening participation in a nationally representative cohort of women in the United States.

Journal of medical screening·2025
Same author

Primary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study.

AIDS (London, England)·2024
Same author

Cervical Cancer Screening Among Female Medicaid Beneficiaries With and Without Schizophrenia.

Schizophrenia bulletin·2024

Related Experiment Video

Updated: Mar 26, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K

Cervical Cancer Screening.

George F Sawaya1, Karen Smith-McCune

  • 1Department of Obstetrics, Gynecology and Reproductive Sciences, the UCSF Center for Healthcare Value, and the UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.

Obstetrics and Gynecology
|February 9, 2016
PubMed
Summary

This study simplifies cervical cancer screening by stratifying women by risk for precancerous lesions and cancer. It emphasizes balancing screening benefits and harms, recommending less frequent screening for most women.

More Related Videos

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

13.8K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K

Related Experiment Videos

Last Updated: Mar 26, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

13.8K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K

Area of Science:

  • Gynecology
  • Oncology
  • Public Health

Background:

  • Cervical cancer screening and management guidelines have evolved with increased understanding of cervical carcinogenesis.
  • Current guidelines aim for a balance between screening benefits and harms, often involving less frequent screening for the general population.
  • Precision in decision-making has introduced complexity into clinical practice.

Purpose of the Study:

  • To provide an overview of cervical cancer screening and management.
  • To guide clinicians in maximizing screening benefits while minimizing harms.
  • To outline risk-stratified management options following colposcopy and recommend cost-effective treatments.

Main Methods:

  • Categorizing women by estimated risk of high-grade precancerous lesions and cervical cancer at each screening step.
  • Reviewing current screening and management guidelines.
  • Outlining three risk-based management options post-colposcopy and evaluating treatment modalities.

Main Results:

  • Current guidelines recommend less frequent screening for most women to balance benefits and harms.
  • Risk assessment is central to management decisions, ensuring consistent referral to colposcopy.
  • Ablational procedures are recommended for treatment when appropriate due to comparable effectiveness, lower cost, and improved safety over excisional procedures.

Conclusions:

  • Clinicians can optimize cervical cancer prevention by adhering to guidelines, promoting human papillomavirus (HPV) vaccination, and ensuring access to affordable, high-quality screening and treatment.
  • New screening strategies should be adopted cautiously, requiring demonstrated cost-effective, patient-centered improvements over existing methods.
  • Risk stratification is key to personalized and effective cervical cancer management.